Javascript must be enabled to continue!
Biomedical Engineering International joins the Family of Platinum Open Access Journals
View through CrossRef
We are delightfully announcing the launch of Biomedical Engineering International, a new interdisciplinary international scholarly open-access journal dedicated to publishing original and innovative research in the field of biomedical engineering. Any type of scientific paper, including reviews, original research papers, communications, or short notes, are welcome to be submitted. Any paper will further undergo the process of peer-reviewing according to the scientific standards of the journal.
The scope of Biomedical Engineering International comprises all the directions of interest for the development of (pre-)clinical applications that could improve the quality of life, from tissue engineering, regenerative medicine, and drug delivery systems, to microfluidics, neural engineering, and micro- and nanotechnology. Thus, Biomedical Engineering International aims to create an interdisciplinary communication tool for scientists in various fields, from chemists, engineers, biologists, to physicists, informaticians, and theoreticians. For this, the publication is done under the policy of Platinum Open Access, meaning that articles are free for readers and no article processing charges are demanded from authors, nor from their institutions. The publication charges for articles in Biomedical Engineering International are covered by AMG Transcend Association, Romania.
Through this, Biomedical Engineering International addresses equality in academic publishing, by making the process available to both researchers and readers. Additionally, authors benefit from increased visibility of their research and thus, an increase of citations and higher influence in the academic world. There are no restrictions on the total length of the papers as the journal encourages the publication of detailed experimental and theoretical research. In this regard, Biomedical Engineering International paves the way to completely free academic publishing services in the biomedical engineering research field.
In this manner, we gladly invite you to submit your papers in the field of biomedical engineering to be considered for publication in Biomedical Engineering International and we are looking forward to collaborating with you!
AMG Transcend Association
Title: Biomedical Engineering International joins the Family of Platinum Open Access Journals
Description:
We are delightfully announcing the launch of Biomedical Engineering International, a new interdisciplinary international scholarly open-access journal dedicated to publishing original and innovative research in the field of biomedical engineering.
Any type of scientific paper, including reviews, original research papers, communications, or short notes, are welcome to be submitted.
Any paper will further undergo the process of peer-reviewing according to the scientific standards of the journal.
The scope of Biomedical Engineering International comprises all the directions of interest for the development of (pre-)clinical applications that could improve the quality of life, from tissue engineering, regenerative medicine, and drug delivery systems, to microfluidics, neural engineering, and micro- and nanotechnology.
Thus, Biomedical Engineering International aims to create an interdisciplinary communication tool for scientists in various fields, from chemists, engineers, biologists, to physicists, informaticians, and theoreticians.
For this, the publication is done under the policy of Platinum Open Access, meaning that articles are free for readers and no article processing charges are demanded from authors, nor from their institutions.
The publication charges for articles in Biomedical Engineering International are covered by AMG Transcend Association, Romania.
Through this, Biomedical Engineering International addresses equality in academic publishing, by making the process available to both researchers and readers.
Additionally, authors benefit from increased visibility of their research and thus, an increase of citations and higher influence in the academic world.
There are no restrictions on the total length of the papers as the journal encourages the publication of detailed experimental and theoretical research.
In this regard, Biomedical Engineering International paves the way to completely free academic publishing services in the biomedical engineering research field.
In this manner, we gladly invite you to submit your papers in the field of biomedical engineering to be considered for publication in Biomedical Engineering International and we are looking forward to collaborating with you!.
Related Results
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Increased life expectancy of heart failure patients in a rural center by a multidisciplinary program
Abstract
Funding Acknowledgements
Type of funding sources: None.
INTRODUCTION Patients with heart failure (HF)...
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
Hubungan Perilaku Pola Makan dengan Kejadian Anak Obesitas
<p><em><span style="font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-langua...
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
...
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Abstract
The rapid growth of open access publishing (OAP) has significantly improved the accessibility and dissemination of scientific knowledge. However, this expansion has also c...
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
<span style="font-size:11pt"><span style="background:#f9f9f4"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><spa...
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: a systematic review and meta-analysis
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: a systematic review and meta-analysis
Abstract
Background
recurrent ovarian cancer (OC) patients with platinum-free interval (PFI) <6 mo. are usually considered p...
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis.
Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis.
e17551 Background: recurrent ovarian cancer (OC) patients with platinum-free interval (PFI) < 6 mo. are usually considered platinum-resistant and treated with non-platinum chem...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...

